MedPath

Very Low Nicotine Cigarettes in Smokers With Schizophrenia

Phase 2
Completed
Conditions
Tobacco Dependence
Interventions
Other: standard nicotine content cigarettes
Other: Very low nicotine content cigarettes
Registration Number
NCT02019459
Lead Sponsor
Brown University
Brief Summary

Smokers with serious mental illness including those with schizophrenia and bipolar disorder infrequently attempt and attain sustained smoking abstinence and have a 25-year shorter lifespan due to smoking-related illness. This study will examine whether reducing the nicotine content of cigarettes to non-addicting levels is a viable method of reducing smoking in smokers with serious mental illness. Smokers will be randomized to one of two experimental conditions: 1) very low nicotine content (VLNC) cigarettes or 2) normal nicotine content (NNC) cigarettes. Participants will be assessed for patterns of tobacco use, biomarkers of exposure, subjective responses (e.g., satisfaction, craving, withdrawal symptoms), psychiatric symptoms, cognitive performance, smoking cue reactivity and smoking topography.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria
  • Age 18-70
  • Schizophrenia, schizoaffective disorder or bipolar disorder
  • Smoke an average of at least 10 cigarettes per day for at least 1 year
  • Breath carbon monoxide (CO) levels >8 ppm (if ≤ 8 ppm, then nicotine (NicAlert) Strip > 2)
Exclusion Criteria
  • Pregnant or nursing
  • Seeking treatment for smoking
  • Medical contraindications

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
0.8 mg nicotine with 10.5 mg tarstandard nicotine content cigarettesSPECTRUM Cigarette: 0.8 (±0.15) mg nicotine yield with 9 (±1.5) mg tar (standard nicotine and tar yields of commercially-available cigarettes; control condition)
0.03 mg nicotine with 9 mg tarVery low nicotine content cigarettesSPECTRUM Cigarette: 0.03 mg (± 0.02) nicotine yield with 9 mg (± 1.5) tar
Primary Outcome Measures
NameTimeMethod
Number of cigarettes smoked per dayEnd of 6 week intervention
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Brown University

🇺🇸

Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath